Regional myocardial perfusion during atrial pacing in patients with coronary artery disease

Circulation
|May 1, 1976
PubMed

Insights

In patients with coronary artery disease (CAD), angina may occur when blockages limit the heart muscle's blood flow response to increased oxygen demand. This study measured regional myocardial perfusion during pacing to assess this response.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Physiology

Background:

  • Coronary artery disease (CAD) affects myocardial perfusion.
  • Assessing the heart's blood flow response to stress is crucial for diagnosing CAD.

Purpose of the Study:

  • To investigate the relationship between obstructive coronary lesions, myocardial oxygen demand, and regional myocardial perfusion (RMP) in patients with and without significant CAD.
  • To determine if impaired RMP response during increased myocardial oxygen demand contributes to angina pectoris.

Main Methods:

  • Regional myocardial perfusion (RMP) was measured using 133xenon and a scintillation camera at rest and during atrial pacing.
  • 24 patients with normal coronary arteriograms (Group I) and 24 with significant left CAD (Group II) were studied.
  • Myocardial oxygen consumption was indexed by the double product (DP) of heart rate and systolic blood pressure.

Main Results:

  • Pacing increased DP similarly in both groups, but RMP response was blunted in Group II (CAD patients).
  • Patients with CAD developed angina more frequently and had a lower response index (RI) compared to Group I.
  • In Group II, RMP distal to lesions showed a significantly smaller increase during pacing than in the rest of the left ventricle (LV).

Conclusions:

  • Obstructive coronary lesions can restrict the heart muscle's blood flow response to increased oxygen demand.
  • This limitation in RMP response may be a mechanism underlying angina pectoris in some patients with CAD.
  • Radiological assessment of collaterals did not consistently correlate with regional perfusion responses.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...